Braintree Laboratories, Inc. operates as a pharmaceutical company that manufactures pharmaceutical products. It offers SUPREP bowel preparation kit, an osmotic laxatives; HalfLytely and Bisacodyl tablet bowel preparation kit, a combination of PEG-3350, an osmotic laxatives and bisacodyl, and stimulant laxatives; NuLYTELY, a prescription medicine for adults and children; GoLYTELY, a lavage preparation solution for diabetic, hypertensive, cardiac, electrolyte imbalance, and renal patients; and Suclear, a sodium sulfate, potassium sulfate, and magnesium sulfate oral solution. The company provides its products for cleansing of colon as a preparation for colonoscopy in adults; and bowel cleansing...
60 Columbian Street West
Braintree, MA 02185-0929
Founded in 1982
Ipsen and Braintree Laboratories Announces Completion of European Decentralized Registration Procedure for Eziclen / Izinova (BLI-800)1
Feb 7 13
Ipsen S.A. and Braintree Laboratories, Inc. announced that Eziclen /Izinova (BLI-800)1 successfully completed its European decentralized registration procedure involving sixteen countries. The product will be indicated in adults for bowel cleansing prior to any procedure requiring a clean bowel (e.g. bowel visualization including bowel endoscopy and radiology or surgical procedure). Each Member States [France (reference member state), Belgium, Czech Republic, Estonia, Germany, Greece, Italy, Latvia, Lithuania, Luxemburg, the Netherlands, Poland, Portugal, Romania, Spain and UK] should now adopt a national decision within 30 days. In practice the grant of the national marketing authorization may vary from one to several months.